Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers to continue to explore the world of gut microbiota.
The annual call for proposals is carried out in countries where Biocodex has a subsidiary presence. An independent local scientific committee – made up of individuals recognized for their expertise in the microbiota field – gathers all proposals and selects the winning project to be granted.
Biocodex Microbiota Foundation in collaboration with Biocodex Microbiota Institute put national winners in the spotlight through testimonies and interviews!
Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers.
Granted projects
2023
Impact de l'antibiothérapie per partum sur le microbiote et mycobiote du lait maternel et sur l'évolution du microbiote et mycobiote intestinal du nouveau-né
PEARL-UTI: Probing the Essential and Adaptive Role of gut, vaginal microbiomes, urobiomes and mucus-like niches in the development of urinary tract infections in early adulthood women: a translational investigation
Bacterial extracellular vesicles as biomarker for Parkinson's disease
2022
Does microbiome composition moderate CNS structure and function in a VPA-induced mouse model of autism?
Mycobiota METabolism Adenosine for Obesity – MMETA4Obesity
Assessment of the intestinal microbiome enterotype and the ability to break down starch in a weight reduction program using nutritional intervention and probiotic therapy in obese women
Role of breast milk mucins in regulation of infant gut microbiota and health
Improving the efficacy of L-dopa therapy of Parkinson’s disease through inhibiting L-dopa conversion to dopamine by intestinal bacteria
Evaluating accumulative effect of antidepressants usage on the gut microbiome